论文部分内容阅读
目的观察参芪扶正注射液与硫酸镁对慢性肺心病心衰及血粘度的影响。方法 6 2例慢性肺心病患者 ,随机分为治疗组 (常规加参芪扶正注射液 )和 32例对照组 (常规加硫酸镁治疗 ) 30例 ,分别观察治疗前后心功能及血粘度。结果治疗组心功能比对照组有显著改善 (P <0 .0 5 ) ;治疗组治疗后血粘度较治疗前有显著改善 (P <0 .0 5 ) ,且与对照组治疗后比较差异有显著性 (P <0 .0 5 ) ;而对照组治疗前后血粘度无明显改善 (P >0 .0 5 )。结论参芪扶正注射液治疗慢性肺心病心衰优于硫酸镁 ,能有效降低血粘度是其重要原因之一。
Objective To observe the effect of Shenqifuzheng injection and magnesium sulfate on heart failure and blood viscosity of chronic cor pulmonale. Methods Sixty patients with chronic pulmonary heart disease were randomly divided into treatment group (conventional plus Shenqi Fuzheng injection) and control group (conventional plus magnesium sulfate) 30 cases, respectively, before and after treatment to observe the cardiac function and blood viscosity. Results Compared with the control group, the cardiac function of the treatment group was significantly improved (P <0.05); the blood viscosity of the treatment group was significantly improved after treatment (P <0.05), and compared with the control group after treatment (P <0.05); while the control group had no significant improvement in blood viscosity before and after treatment (P> 0.05). Conclusion Shenqi Fuzheng injection is superior to magnesium sulfate in the treatment of chronic cor pulmonale heart failure, which can effectively reduce the blood viscosity is one of the important reasons.